Divozilimab (Anti-CD20)
Divozilimab (BCD-132) is a humanised monoclonal antibody against CD20 (CD20) with the potential to be used in multiple sclerosis research. MW : 145.26 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2823 |
| Sku # | A2823-1mg |
| Pricing | 1mg, $370.00 |